Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001601830-25-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | 2025-02-18 | RXRX | Taylor Ben R | CFO | F - Tax | $10.64 | -10.9K | 875.7K | -1% | -$115.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-18 | F | D | 10,879 | $10.64 | 875,727 | D | — | — |